Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient
- 1,
- 1,
- 1,
- 1,
- 1,
- 1,
- 1,
- 1*,
- 1
- 1Departments of Pharmacology and Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Bikash Medhi
Departments of Pharmacology and Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Email: drbikashus@yahoo.com
Copyright: © 2017 The Author(s). This is an open access article.
Published: Jan 1, 2017, Received: Mar 18, 2017, Accepted: Aug 9, 2017
Abstract
Terlipressin is used commonly in the management of hepatorenal syndrome and acute variceal bleeding. Like its parent compound vasopressin, it is also notorious for its ischemic complications. Terlipressin-induced ischemic complications can virtually affect any part of the body, but the incidence of serious complications is less than its parent compound vasopressin. Here, we report a case of terlipressin-induced peripheral ischemic gangrene in a diabetic male, which ultimately led to death of the patient.
Keywords
Subject
Recommended articles
- Selective Partial Agonism of Vasopressin 1a Receptors In Vitro by OCE-205
Glenn Croston, Edward E. Cable, Jeannine Toy · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026